Project Grant R01AI191312
- Federal Grant Award Summary Trustees of Dartmouth College received a $246,562 Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded June 6, 2025, with completion scheduled for February 28, 2027. The research project, conducted at Dartmouth's Hanover, New Hampshire facilities, focuses on understanding how hypoxia-associated morphological variations in Aspergillus fumigatus (AF)—a common...
- Federal Grant Award Summary Dartmouth College, through its Office of Sponsored Projects, received a Project Grant award of $105,076 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award was obligated on December 20, 2025, with a completion date of July 31, 2027, and supports research to be conducted in New Hampshire. The grant funds basic biomedical research investigating the dual functionality...
- Federal Project Grant Award Summary Award Details: The National Institute of Allergy and Infectious Diseases (NIAID) awarded Dartmouth College a Project Grant totaling $825,054 under the Allergy and Infectious Diseases Research program (CFDA 93.855), with an award date of February 13, 2026 and completion date of January 31, 2031. Research Deliverables: This project will advance scientific understanding of how Type VI Secretion System (T6SS) immunity proteins influence airway microbiota...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases awarded the University of Massachusetts Medical School a $853,537 Project Grant on August 8, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate fungal melanin modulation of calcium-mediated immune responses in lung epithelium. The research addresses invasive pulmonary fungal infections caused by Aspergillus fumigatus, which impose significant health and economic...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Tennessee Health Science Center a $121,752 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective November 1, 2025, with completion targeted for April 14, 2027. This award supports investigative research titled "Interrogation of SIDB-Dependent Septation for Echinocandin Potentiation in Invasive Aspergillosis Treatment,"...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Dartmouth-Hitchcock Clinic a Project Grant totaling $232,500 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective February 9, 2026, with a completion date of January 31, 2028. The project, titled "Multiplexed Reporter Platforms for Probing the Bile Acid-Nuclear Receptor Interactome," involves the development and deployment of innovative multiplex nuclear...
- Federal Grant Award Summary Brigham & Women's Hospital, Inc. received a $3.08 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on February 5, 2026, with performance through January 31, 2030. The project, titled "TH2 Memory in Chronic Type 2 Inflammation," focuses on understanding the mechanisms that sustain aberrant Type 2 T helper cell progenitor...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $200,340 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, Berkeley, effective August 22, 2025, through July 31, 2030. This K01 Career Development Award supports Dr. Brittany L. Morgan Bustamante's research to advance epidemiological understanding of three invasive fungal diseases—aspergillosis, candidiasis, and...
- Federal Project Grant Award Summary Harvard Medical School received a $570,760 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 1, 2025 through August 31, 2030. This five-year research initiative will deliver fundamental scientific research investigating the mechanistic and structural basis of intraflagellar transport (IFT) in Leishmania parasites, which are...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $3.18 million Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855) awarded August 19, 2025, with completion anticipated by July 31, 2029. The award supports the development of innovative research technologies and methodologies to investigate host-microbiome-pathogen interactions in the lung....
Award Details: Dartmouth College received a $630,677 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award, obligated on February 2, 2026, supports a five-year research project extending through January 31, 2031, with performance conducted at the Hanover, New Hampshire campus. Research Products and Services: The grant funds biomedical research investigating the mechanisms by which Aspergillus fumigatus persists within alveolar macrophages to drive chronic aspergillosis, with particular emphasis on allergic bronchopulmonary aspergillosis (ABPA) in individuals with cystic fibrosis. Working in collaboration with the Dartmouth Cystic Fibrosis Research Center, the research team will develop and utilize a novel ABPA murine model to examine both fungal and host factors enabling long-term fungal persistence. Specific research activities include identifying fungal-intrinsic pathways supporting Aspergillus fumigatus survival within lung-resident macrophages and evaluating whether clinical isolates from cystic fibrosis patients demonstrate selection of these persistence pathways, alongside investigation of host immune pathways within alveolar macrophages that influence susceptibility to fungal colonization and disease progression.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $630.7k | 2/2/26 |